Health IT

OnShift releases new version of staff scheduling software for LTC facilities

OnShift has released a new version of its web-based staff scheduling software for long-term care providers and nursing homes. The new version includes enhancements to the software’s reporting and analytics capabilities, as well as a new feature called Staff Extend, according to a statement from the Cleveland-based company. With Staff Extend providers can fill shifts […]

OnShift has released a new version of its web-based staff scheduling software for long-term care providers and nursing homes.

The new version includes enhancements to the software’s reporting and analytics capabilities, as well as a new feature called Staff Extend, according to a statement from the Cleveland-based company.

With Staff Extend providers can fill shifts by accessing and sharing employees from neighboring locations, such as a sister community or facility. OnShift automatically identifies qualified and available staff from neighboring locations, red flags conflicting schedule assignments and overtime risks, and communicates openings with potential replacements via text message, email and automated phone call, according to the company’s blog.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Last month, OnShift reported that it closed a $3 million series B round of funding. The company also recently was approved for a $512,000 loan from the state of Ohio.

The young company enjoyed solid growth last year, with revenue rising 400 percent over 2010. OnShift is aiming for a similar rate of growth this year, CEO Mark Woodka said earlier this year.